The Ministry of Health (MoH) has raised the alarm on two cosmetic products, tested by the Laboratory of Pharmacy Section, Department of Scientific Services, MoH and found to be adulterated with undeclared, potent Western medicine.
The cosmetic products are:
– Dollys Pinky Night Advanced Cream, adulterated with Mercury. (Manufacturer unknown).
– Wardah Lightening Night Cream, adulterated with Mercury (Manufacturer – PT Paragon Technology and Innovation, Indonesia)
The adulterant found in this product can cause adverse effects potentially hazardous to users.
Mercury is a potent ingredient prohibited in cosmetic products as stipulated in the Medicines (Cosmetic Products) Regulations 2007. It is prohibited due to its hazardous effects on human health. It is readily absorbed through the skin on topical application and tends to accumulate in the body.
Exposure to Mercury can cause skin rashes, memory loss and muscle weakness, while high exposures may result in damage to the brain and kidneys. It is also extremely toxic to unborn children.
The MoH has not issued any approval for the importation for the sale of these products and/or Cosmetic Notification Acknowledgement Letter for the sale of the rest of the affected products.
Following these findings, the products are not allowed to be imported and sold in Brunei.
Members of the public who have purchased or used these products are advised to stop using them immediately. They should also consult a medical practitioner if they feel unwell or experience any undesirable reactions as a result of using them.
Members of the public involved in the retail of these products (including online retail such as through Facebook, etc) are reminded that it is an offence under the Medicines (Cosmetic Products) Regulations, 2007 to import and market cosmetic products in the local market without a Cosmetic Product Notification Acknowledgement Letter issued by the Authority. The penalty for contravening these regulations upon conviction, is a fine not exceeding BND5,000, imprisonment for a term not exceeding two years or both.
The MoH called on the public to report to the Compliance and Licensing Section if any of these products are still found on the market in this country.
The public can contact the Compliance and Licensing Section at 2393298 (ext 208); e-mail [email protected]; visit the 1st Floor, Compliance and Licensing Section, Department of Pharmaceutical Services’ Building in Kampong Madaras, Mukim Gadong ‘A;’ or call Darussalam hotline 123 for further information and communication.